GFAP and polyostotic fibrous dysplasia: We also found a faded alpha-SMA positive area, indicating a contracted activation of HSCs due to PFD treatment; which correlates with an increase in GFAP (Glial fibrillary acidic protein) quiescent marker in HSCs in these group.